Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.
about
Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity.Antitumor Effect of KML-B-Treated Dendritic Cells via Induction of Lymphocyte Activation.Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein X.A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy.The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4Mycobacterium abscessus MAB2560 induces maturation of dendritic cells via Toll-like receptor 4 and drives Th1 immune responseHost responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling.Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes.Mycobacterial Heparin-binding Hemagglutinin Antigen Activates Inflammatory Responses through PI3-K/Akt, NF-κB, and MAPK Pathways.Heat shock protein X purified from Mycobacterium tuberculosis enhances the efficacy of dendritic cells-based immunotherapy for the treatment of allergic asthma.Antitumor and Adjuvant Activity of λ-carrageenan by Stimulating Immune Response in Cancer ImmunotherapyHerbal preparation (HemoHIM) enhanced functional maturation of bone marrow-derived dendritic cells mediated toll-like receptor 4.Resveratrol regulates naïve CD 8+ T-cell proliferation by upregulating IFN-γ-induced tryptophanyl-tRNA synthetase expressionMycobacterium paratuberculosis CobT activates dendritic cells via engagement of Toll-like receptor 4 resulting in Th1 cell expansion.Roles of Mucosal Immunity against Mycobacterium tuberculosis InfectionMycobacterium leprae Activates Toll-Like Receptor-4 Signaling and Expression on Macrophages Depending on Previous Bacillus Calmette-Guerin VaccinationMycobacterium abscessus D-alanyl-D-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity.The potential of plants for the production and delivery of human papillomavirus vaccines.Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.Mycobacterium tuberculosis promotes Th17 expansion via regulation of human dendritic cells toward a high CD14 and low IL-12p70 phenotype that reprograms upon exogenous IFN-γ.Genetic Diversity of Toll-Like Receptors and Immunity to M. leprae Infection.Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells.Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.Collagen I enhances the efficiency and anti-tumor activity of dendritic-tumor fusion cells.Mycobacterium tuberculosis GrpE, A Heat-Shock Stress Responsive Chaperone, Promotes Th1-Biased T Cell Immune Response via TLR4-Mediated Activation of Dendritic Cells.Lycium barbarum Polysaccharide Promotes Maturation of Dendritic Cell via Notch Signaling and Strengthens Dendritic Cell Mediated T Lymphocyte Cytotoxicity on Colon Cancer Cell CT26-WT.MAP1981c, a Putative Nucleic Acid-Binding Protein, Produced by Mycobacterium avium subsp. paratuberculosis, Induces Maturation of Dendritic Cells and Th1-Polarization.
P2860
Q33763393-2C19EC62-BF03-46F4-96FC-FE261553CD11Q33786891-34F8C97B-9B8B-419B-BCE5-64E7FC011FE9Q33927138-56588472-05CD-4C94-AC7C-9ED00B3615F3Q34015759-252B34DD-AE41-44DE-8D61-7BB9E444F008Q34180146-D13480D7-0F85-49D6-B96E-285C18EDE5E9Q34389773-4EAC06F7-9480-4D23-97FC-86ECD8802B6FQ34575866-BC9E79C4-ECEB-434A-A4F7-6F42C0012B88Q34993170-279B7A2F-8B2F-49F2-B01B-87A9498B7A6AQ35000960-17E6C629-2E91-4A86-9017-E263F53879B8Q35676339-B6933C81-9EE9-4EB5-B8DB-774A2A243996Q35766482-A6F19DB6-C9A7-48CA-996F-1D32E91C5637Q35927737-9EFC0B84-CEAA-4C1A-A800-8B66528313ADQ36082436-FCFB3A92-EFDE-4DF6-856D-1CF4B5319944Q36385801-B25291D0-CFF2-4047-89FA-AD1BD130DF5EQ36417953-E238B09A-B14B-4AE7-9D17-7FD551A281CFQ37075508-CE9E23F5-DE5E-4C4C-BC29-6DD3FB057E31Q37581285-DFE22B41-F485-40F4-88A0-783489726C44Q38424974-1B43AFB7-B6BE-429D-A319-87C3640D6EF6Q39237839-FC608A08-CEF0-4985-A5B6-37BE6D088FB4Q40131760-5B6201DC-9A08-44FF-BAC4-53F0E347C0DDQ40722407-AE865890-9279-4966-884B-EAEDD876BCF9Q41738784-5210F13D-1CD8-416A-A942-F4C30D6DD6DEQ41980154-C048605B-DB69-435D-8204-EB651FAD6648Q44400658-4AFFE9F3-E3B5-48E3-A315-26EA7ADA509BQ44512725-EF4B5748-43C1-4F8B-B275-3F3EE6557A54Q45344940-52B917AD-491B-4421-91E9-4A6A08E0D80CQ50433335-6A553084-20EC-4BAF-9230-4D7A65AC32C9Q52595010-ADCEEC9E-25DF-4D0A-A090-8CA9C759FE0DQ52606111-37E3665F-D2BA-4442-B260-E29FC51FEE0FQ55416755-8EF92F66-EF40-4B5D-9B86-B7D2FAFC27C6
P2860
Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Enhanced efficacy of therapeut ...... lutinin, a novel TLR4 agonist.
@en
Enhanced efficacy of therapeut ...... lutinin, a novel TLR4 agonist.
@nl
type
label
Enhanced efficacy of therapeut ...... lutinin, a novel TLR4 agonist.
@en
Enhanced efficacy of therapeut ...... lutinin, a novel TLR4 agonist.
@nl
prefLabel
Enhanced efficacy of therapeut ...... lutinin, a novel TLR4 agonist.
@en
Enhanced efficacy of therapeut ...... lutinin, a novel TLR4 agonist.
@nl
P2093
P1433
P1476
Enhanced efficacy of therapeut ...... lutinin, a novel TLR4 agonist.
@en
P2093
Chang-Min Lee
Cheol-Heui Yun
Deok Rim Heo
Hwa-Jung Kim
In Duk Jung
Jake Whang
Kyung Tae Noh
Shizuo Akira
Soo Kyung Jeong
Sung Jae Shin
P304
P356
10.1158/0008-5472.CAN-10-3487
P407
P577
2011-03-02T00:00:00Z